LHCAX holdings — Lord Abbett Health Care Fund
Lord Abbett Health Care Fund (LHCAX) held 61 positions with net assets of $8.56M as of July 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 42.9% of the fund, led by LLY, UNH, JNJ.
LHCAX top holdings
- LLY Eli Lilly & Co — 10.40% ($890K)
- UNH UnitedHealth Group Inc — 5.39% ($462K)
- JNJ Johnson & Johnson — 4.96% ($425K)
- Novartis AG — 4.19% ($358K)
- NTRA Natera Inc — 3.60% ($308K)
- GILD Gilead Sciences Inc — 3.53% ($302K)
- CVS CVS Health Corp — 3.33% ($286K)
- GH Guardant Health Inc — 2.61% ($224K)
- Galderma Group AG — 2.60% ($223K)
- TMO Thermo Fisher Scientific Inc — 2.31% ($198K)
- COGT Cogent Biosciences Inc — 2.26% ($194K)
- VRTX Vertex Pharmaceuticals Inc — 2.24% ($192K)
- TXG 10X Genomics Inc — 2.16% ($185K)
- BeOne Medicines Ltd — 2.06% ($176K)
- Ascendis Pharma A/S — 1.99% ($170K)
- AstraZeneca PLC — 1.97% ($169K)
- MDGL Madrigal Pharmaceuticals Inc — 1.91% ($164K)
- BBIO Bridgebio Pharma Inc — 1.84% ($158K)
- EW Edwards Lifesciences Corp — 1.78% ($153K)
- RVMD Revolution Medicines Inc — 1.67% ($143K)
- ARWR Arrowhead Pharmaceuticals Inc — 1.52% ($130K)
- PTGX Protagonist Therapeutics Inc — 1.44% ($124K)
- DNTH Dianthus Therapeutics Inc — 1.44% ($123K)
- ADPT Adaptive Biotechnologies Corp — 1.42% ($122K)
- ILMN Illumina Inc — 1.42% ($122K)
What are LHCAX's top 10 holdings?
LLY (10.4%), UNH (5.4%), JNJ (5.0%), Novartis AG (4.2%), NTRA (3.6%), GILD (3.5%), CVS (3.3%), GH (2.6%), Galderma Group AG (2.6%), TMO (2.3%).
How many stocks are in LHCAX?
Lord Abbett Health Care Fund reported 61 holdings as of July 31, 2026.
Share classes: LHCAX, LHCCX, LHCFX, LHCIX, LHCOX, LHCQX, LHCSX, LHCTX, LHCVX